Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic Data from this combination trial…
– Company seeks proposals to create and sustain community-focused programs to support underserved populations with these conditions – VICTORIA, British…